Embracer Group (EMBRAC) AGM 2025 summary
Event summary combining transcript, slides, and related documents.
AGM 2025 summary
6 Oct, 2026Opening remarks and agenda
Chair welcomed in-person and online participants; agenda covered presentations, market update, Q&A and formal AGM proceedings.
Formal business included voting-list approval, election of meeting chair, minute certification and confirmation of proper convening.
Financial performance review
FY 2024/25 net sales were SEK 22,370m, down 18% YoY and 9% organically; adjusted EBIT was SEK 3,344m, down 33%.
Free cash flow improved to SEK 1,351m from SEK -819m, while year-end net cash reached SEK 5.4bn.
Divestments and spin-offs, including Asmodee, Easybrain and Gearbox, supported cash generation and debt reduction; Asmodee listed on Nasdaq Stockholm in February.
Adjusted EBIT margin was pressured by revenue mix changes and fewer new releases.
Headcount nearly halved since 2022/23, alongside a streamlined project pipeline.
Board and executive committee updates
Seven directors were re-elected: Jacob Jonmyren, Kicki Wallje-Lund, Lars Wingefors, Yasmina Brihi, Bernt Ingman, Cecilia Qvist and Brian Ward.
Lars Wingefors became Board Chair after stepping down as CEO; Kicki Wallje-Lund was appointed Deputy Chair, and committee memberships were confirmed.
PwC was re-elected auditor, with Magnus Svensson Henryson remaining main responsible auditor.
Latest events from Embracer Group
- FY sales fell 25% as Fellowship’s planned spin-off and cash generation shaped priorities.EMBRAC
AGM 2026 - Net sales up 24% YoY, Cash EBIT positive, and FY 2026/27 outlook for SEK 1.0bn reaffirmed.EMBRAC
Q1 26/27 - Separation into two listed companies announced, with strong Q4 cash flow and SEK 1B+ Cash EBIT guidance.EMBRAC
Q4 25/26 - Q3 sales dropped 26% YoY, but core IPs outperformed and EBIT guidance is SEK 750 million.EMBRAC
Q3 25/26 - Lean teams, strong IPs, and SEK 500m net cash drive growth and shareholder returns.EMBRAC
Coffee Stain CMD 2025 - All proposals passed as the group restructures into three listed entities with strong sales growth.EMBRAC
AGM 2024 - Targets >18% EBITDA margin, mid-single digit growth, and lower leverage after EUR 400m investment.EMBRAC
Asmodee CMD 2024 - Sales and EBIT dropped, but cash flow and debt improved as spin-off plans progressed.EMBRAC
Q1 24/25 - Q4 organic growth, strong cash flow, and Coffee Stain spin-off set stage for future expansion.EMBRAC
Q4 24/25